The Trump administration on Monday announced federal officials are launching investigations into Harvard University and the ...

“Mexico has committed to make an immediate transfer of water from international reservoirs and increase the U.S. share of the ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

At the insistence of Justice Neil Gorsuch, she withdrew the allegation that the other side had lied but held firm to the ...

The coal industry once provided more than half of U.S. electricity production. But it has been in steep decline for decades ...

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...

Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay. The Secretary of Health and Human Services ...

"If they don't approve Novavax, they put every COVID vaccine at risk," Jefferies analyst Roger Song said, adding that the Novavax vaccine works "as good as, if not better than other COVID vaccines".

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 ...